Equities

VentriPoint Diagnostics Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

VentriPoint Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.125
  • Today's Change0.005 / 4.17%
  • Shares traded151.31k
  • 1 Year change+25.00%
  • Beta0.1694
Data delayed at least 15 minutes, as of Feb 06 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, VentriPoint Diagnostics Ltd (VPT:CVE) closed at 0.125, 66.67% above the 52 week low of 0.075 set on Feb 25, 2025.
52-week range
Today
0.075Feb 25 20250.20Mar 24 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.115
High0.125
Low0.115
Bid0.125
Offer0.13
Previous close0.12
Average volume84.32k
Shares outstanding181.87m
Free float179.07m
P/E (TTM)--
Market cap21.82m CAD
EPS (TTM)-0.0248
CAD
Data delayed at least 15 minutes, as of Feb 06 2026 20:59 GMT.
More ▼

Events & Activity

  • VPT:CVE price moved over -4.17% to 0.115
  • VPT:CVE price falls below 200-day moving average to 0.115 at 14:30 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.